We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
(-18%)
Cap. Flow
-$198M
Cap. Flow
% of AUM
-15.04%
Top 10 Holdings %
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$9.86M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$9.7M |
| 3 |
CNR
Core Natural Resources Inc
CNR
|
+$8.26M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$6.63M |
| 5 |
Oracle
ORCL
|
+$6.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMAR
Smartsheet Inc.
SMAR
|
+$14M |
| 2 |
HTLF
Heartland Financial USA, Inc.
HTLF
|
+$11.1M |
| 3 |
NVIDIA
NVDA
|
+$9.36M |
| 4 |
Amazon
AMZN
|
+$8.75M |
| 5 |
Netflix
NFLX
|
+$8.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.2% |
| 2 | Healthcare | 10.48% |
| 3 | Consumer Discretionary | 9.93% |
| 4 | Financials | 7.26% |
| 5 | Communication Services | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Arcutis Biotherapeutics
ARQT
$3.26B
| $361K | 0.03% |
+23,085
| New | +$325K |
|
627
Targa Resources
TRGP
$57.1B
| $360K | 0.03% |
+1,798
| New | +$357K |
|
628
Nexstar Media Group
NXST
$5.91B
| $360K | 0.03% |
+2,010
| New | +$325K |
|
629
Cencora
COR
$62B
| $355K | 0.03% |
1,278
-410
| -24% | -$103K |
|
630
Marathon Petroleum
MPC
$90B
| $353K | 0.03% |
+2,425
| New | +$359K |
|
631
Molson Coors Class B
TAP
$7.93B
| $353K | 0.03% |
+5,794
| New | +$334K |
|
632
Essential Utilities
WTRG
$11.3B
| $352K | 0.03% |
8,910
-7,380
| -45% | -$271K |
|
633
Xcel Energy
XEL
$48B
| $351K | 0.03% |
4,965
-8,830
| -64% | -$601K |
|
634
Cal-Maine
CALM
$3.85B
| $351K | 0.03% |
3,856
+1,492
| +63% | +$147K |
|
635
Archer Daniels Midland
ADM
$38.8B
| $350K | 0.03% |
+7,284
| New | +$352K |
|
|
NESR
636
National Energy Services Reunited Corp
NESR
$3.61B
| $349K | 0.03% |
47,368
-134,689
| -74% | -$1.16M |
|
637
ExxonMobil
XOM
$662B
| $349K | 0.03% |
2,931
-20,652
| -88% | -$2.28M |
|
638
Texas Roadhouse
TXRH
$13.6B
| $348K | 0.03% |
2,088
+625
| +43% | +$111K |
|
|
CALY
639
Callaway Golf Company
CALY
$3.04B
| $346K | 0.03% |
52,500
| – | – |
|
|
CCIR
640
DELISTED
Cohen Circle Acquisition Corp. I Class A Ordinary Shares
CCIR
| $345K | 0.03% |
+30,793
| New | +$340K |
|
641
TAL Education Group
TAL
$6.93B
| $344K | 0.03% |
+26,042
| New | +$325K |
|
642
SelectQuote
SLQT
$123M
| $344K | 0.03% |
102,975
+37,401
| +57% | +$159K |
|
643
CALL
Synopsys
SNPS
$78.8B
| $343K | 0.03% |
+800
| New | +$389K |
|
644
Helix Energy Solutions
HLX
$1.47B
| $342K | 0.03% |
+41,170
| New | +$347K |
|
645
Leidos
LDOS
$17.5B
| $339K | 0.03% |
2,514
-3,617
| -59% | -$505K |
|
646
Dover
DOV
$28.3B
| $339K | 0.03% |
+1,928
| New | +$371K |
|
647
Allegiant Air
ALGT
$2.41B
| $338K | 0.03% |
+6,542
| New | +$526K |
|
648
Autoliv
ALV
$8.92B
| $338K | 0.03% |
+3,816
| New | +$363K |
|
|
QXO
649
QXO Inc
QXO
$16.6B
| $337K | 0.03% |
+24,921
| New | +$339K |
|
650
US Foods
USFD
$23.9B
| $336K | 0.03% |
5,130
+1,252
| +32% | +$85.6K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.
- Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
- Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
- Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
- Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
- Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
- Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
- Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.
Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.